-
1دورية أكاديمية
المؤلفون: Tian Cuimeng, Liu Guimei, Xu Yongxiang, Xia Guangrong, Zhang Tongmei, Huang Jiaqiang, Jiang Hui, Ming Wang Ji, Li Baolan
المصدر: Radiology and Oncology, Vol 55, Iss 1, Pp 66-76 (2020)
مصطلحات موضوعية: lung squamous cell carcinoma, lung adenocarcinoma, piiia-n2, postoperative radiotherapy, Medical physics. Medical radiology. Nuclear medicine, R895-920
وصف الملف: electronic resource
Relation: https://doaj.org/toc/1581-3207
-
2مؤتمر
المؤلفون: Xia Guangrong, Liu Xingzhao
المصدر: 6th International Conference on Signal Processing, 2002. Signal processing proceedings Signal Processing, 2002 6th International Conference on. 1:182-185 vol.1 2002
Relation: Proceedings of International Conference on Signal Processing (ICSP)
-
3دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
4دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
5
المؤلفون: Liu Xing-zhao, Xia Guangrong
المصدر: 6th International Conference on Signal Processing, 2002..
مصطلحات موضوعية: Normal distribution, Uniform distribution (continuous), Half-normal distribution, Characteristic function (probability theory), Cumulative distribution function, Probability distribution, Algorithm, Symmetric probability distribution, Stable distribution, Mathematics
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::29ebc738828d744b4ce4e95d44e4f64b
https://doi.org/10.1109/icosp.2002.1181020 -
6مؤتمر
المؤلفون: Xia Guangrong, Liu Xingzhao
المصدر: 6th International Conference on Signal Processing, 2002; 2002, p182-182, 1p
-
7دورية أكاديمية
المؤلفون: Liu G; Department of Radiotherapy, Beijing Chest Hospital, Capital Medicine University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing 101149, China., Zhang X; Department of Medical Oncology, Beijing Chest Hospital, Capital Medicine University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing 101149, China., Tian C; Department of Radiotherapy, Beijing Chest Hospital, Capital Medicine University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing 101149, China., Xia G; Department of Radiotherapy, Beijing Chest Hospital, Capital Medicine University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing 101149, China., Liu P; Department of Medical Oncology, Beijing Chest Hospital, Capital Medicine University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing 101149, China., Zhang Q; Department of Medical Oncology, Beijing Chest Hospital, Capital Medicine University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing 101149, China., Li X; Department of Medical Oncology, Beijing Chest Hospital, Capital Medicine University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing 101149, China., Zhang H; Department of Medical Oncology, Beijing Chest Hospital, Capital Medicine University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing 101149, China., Qin N; Department of Medical Oncology, Beijing Chest Hospital, Capital Medicine University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing 101149, China., Wang J; Department of Medical Oncology, Beijing Chest Hospital, Capital Medicine University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing 101149, China., Zhang S; Department of Medical Oncology, Beijing Chest Hospital, Capital Medicine University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing 101149, China.
المصدر: Zhongguo fei ai za zhi = Chinese journal of lung cancer [Zhongguo Fei Ai Za Zhi] 2016 Aug 20; Vol. 19 (8), pp. 501-7.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Zhongguo fei ai za zhi bian ji wei yuan hui Country of Publication: China NLM ID: 101126433 Publication Model: Print Cited Medium: Internet ISSN: 1999-6187 (Electronic) Linking ISSN: 10093419 NLM ISO Abbreviation: Zhongguo Fei Ai Za Zhi Subsets: MEDLINE
مواضيع طبية MeSH: Cranial Irradiation*/adverse effects , Mutation*, Brain Neoplasms/*radiotherapy , Brain Neoplasms/*secondary , Carcinoma, Non-Small-Cell Lung/*pathology , ErbB Receptors/*genetics , Lung Neoplasms/*pathology, Adult ; Aged ; Aged, 80 and over ; Carcinoma, Non-Small-Cell Lung/drug therapy ; Carcinoma, Non-Small-Cell Lung/genetics ; Disease-Free Survival ; ErbB Receptors/antagonists & inhibitors ; Female ; Humans ; Lung Neoplasms/drug therapy ; Lung Neoplasms/genetics ; Male ; Middle Aged ; Protein Kinase Inhibitors/pharmacology ; Protein Kinase Inhibitors/therapeutic use ; Retrospective Studies ; Treatment Outcome